HP
71
6
WFC
41
-9
KLAC
49
2
NAVI
41
9
DO
48
4
KO
50
3
FLR
66
4
PFE
37
4
AN
46
3
VMC
63
4
NEM
52
-3
CVX
44
3
LEN
38
4
DVN
64
6
AMT
30
-2
CB
65
3
CHK
68
3
WU
42
2
AIG
51
15
BLK
46
3
HP
71
6
WFC
41
-9
KLAC
49
2
NAVI
41
9
DO
48
4
KO
50
3
FLR
66
4
PFE
37
4
AN
46
3
VMC
63
4
NEM
52
-3
CVX
44
3
LEN
38
4
DVN
64
6
AMT
30
-2
CB
65
3
CHK
68
3
WU
42
2
AIG
51
15
BLK
46
3
Financhill
Back

Bristol-Myers Squibb 10K Form

Buy
68

BMY
Bristol-Myers Squibb

Last Price:
62.01
Seasonality Move:
4.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $46.16B
Cash Flow: $1.63B
Price / Cash Flow: 12.27
Annual Sales: $15.31
Price / Book: 4.05

Profitability

EPS (TTM): 3.76000
Net Income (TTM): $7.96B
Gross Margin: $36.02B
Return on Equity: 24.86%
Return on Assets: 8.24%

Bristol-Myers Squibb Earnings Forecast

Key Bristol-Myers Squibb Financial Ratios

  • The Gross Profit Margin over the past 36 years for BMY is 78.04%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 16.93% of Gross Profit Margin.
  • The Research & Development expenses have been 20.60% of Revenue.
  • The Interest Expense is 19.47% of Operating Income.
  • The Net Earning history of BMY is 13.71% of Total Revenues.
  • Per Share Earnings over the last 36 years have been positive in 18 years.

Bristol-Myers Squibb Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 1.18
Current Ratio: 1.39
Quick Ratio: 1.18

Price-to-Earnings

Trailing P/E Ratio: 21.02
Forward P/E Ratio: 7.85

BMY Technical Analysis vs Fundamental Analysis

Buy
68
Bristol-Myers Squibb (BMY) is a Buy

Is Bristol-Myers Squibb a Buy or a Sell?